Join to view full profile
8613 Route 29200Fairfax, VA 22031
Phone+1 571-350-8400
Fax+1 703-940-8746
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Dipti Patel-Donnelly, MD is an oncologist in Fairfax, Virginia. She is currently licensed to practice medicine in Virginia. She is affiliated with Inova Fairfax Medical Campus and Inova Fair Oaks Hospital.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2000 - 2003
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1996 - 1999
Icahn School of Medicine at Mount SinaiClass of 1996
Certifications & Licensure
VA State Medical License 2003 - 2026
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification iKnowMed EHR, McKesson, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification iKnowMed EHR, McKesson, 2012, 2014-2017
Publications & Presentations
PubMed
- 36 citationsBrentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy.Jonathan W Friedberg, Rodolfo Bordoni, Dipti Patel-Donnelly, Timothy Larson, Jerome Goldschmidt
Blood. 2024-02-29 - Acute leukemias and complicated lymphomas: pearls to optimize management when patients stay local.Dipti Patel-Donnelly, Mitul Gandhi
Hematology. American Society of Hematology. Education Program. 2023-12-08 - 1 citationsSafety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaJason R. Westin, Michael B. Maris, Caron A. Jacobson, Prapti A. Patel, Nehal Lakhani
Clinical Lymphoma, Myeloma & Leukemia. 2021-07-25
Press Mentions
Danijela Jelovac, MD Joins Virginia Cancer SpecialistsSeptember 25th, 2024
Managing Acute Leukemias and Lymphomas When Patients Stay Local with Dipti Patel-Donnelly, MDFebruary 1st, 2024










